Tuesday, October 26, 2004

Combination SSRI and CBT Most Effective for Adolescent Depression
Medscape Medical News story - "Adolescents with major depressive disorder are more likely to respond to a combination of the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac) and cognitive behavioral therapy (CBT) than to either as monotherapy, according to investigators of a publicly funded study who presented their findings here at the 51st annual meeting of the American Academy of Child and Adolescent Psychiatry (AACAP). In addition, the researchers found that the combination — and each therapy alone — were more effective than placebo, said principal investigator John S. March, MD. He spearheaded the Teenage Depression Study (TADS), which was funded by the National Institute of Mental Health..." [Viewing Medscape resources requires registration, which is free].